Goldman Sachs Initiates Coverage On iRhythm Technologies with Neutral Rating, Announces Price Target of $78
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs has initiated coverage on iRhythm Technologies with a Neutral rating and set a price target of $78.
October 04, 2024 | 11:40 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Goldman Sachs has initiated coverage on iRhythm Technologies with a Neutral rating and a price target of $78, indicating a balanced view on the stock's potential.
The Neutral rating suggests that Goldman Sachs sees no immediate upside or downside potential in iRhythm Technologies' stock. The price target of $78 provides a benchmark for investors, but the neutral stance indicates a balanced view, likely resulting in a stable short-term stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100